|
US6777217B1
(en)
|
1996-03-26 |
2004-08-17 |
President And Fellows Of Harvard College |
Histone deacetylases, and uses related thereto
|
|
US20030129724A1
(en)
|
2000-03-03 |
2003-07-10 |
Grozinger Christina M. |
Class II human histone deacetylases, and uses related thereto
|
|
EP1539744A4
(en)
*
|
2002-07-11 |
2007-06-06 |
Vicuron Pharm Inc |
N-HYDROXYAMIDE DERIVATIVES WITH ANTIBACTERIAL EFFECT
|
|
SG2012000667A
(en)
*
|
2003-01-08 |
2015-03-30 |
Univ Washington |
Antibacterial agents
|
|
CA2532965C
(en)
|
2003-07-22 |
2013-05-14 |
Astex Therapeutics Limited |
3, 4-disubstituted 1h-pyrazole compounds and their use as cyclin dependent kinases (cdk) and glycogen synthase kinase-3 (gsk-3) modulators
|
|
JP4667384B2
(ja)
*
|
2003-10-07 |
2011-04-13 |
レノビス， インコーポレイテッド |
イオンチャネルリガンドとしてのアミド誘導体および薬学的組成物、ならびにこれらを使用する方法
|
|
CA2548442A1
(en)
*
|
2003-12-19 |
2005-07-07 |
Basf Aktiengesellschaft |
Benzoyl-substituted phenylalanine amides
|
|
US7468428B2
(en)
|
2004-03-17 |
2008-12-23 |
App Pharmaceuticals, Llc |
Lyophilized azithromycin formulation
|
|
US7638513B2
(en)
|
2004-06-02 |
2009-12-29 |
Schering Corporation |
Compounds for the treatment of inflammatory disorders
|
|
WO2006022442A1
(ja)
*
|
2004-08-24 |
2006-03-02 |
Santen Pharmaceutical Co., Ltd. |
ジヒドロオロテートデヒドロゲナーゼ阻害活性を有する新規複素環アミド誘導体
|
|
US7776869B2
(en)
|
2004-10-18 |
2010-08-17 |
Amgen Inc. |
Heteroaryl-substituted alkyne compounds and method of use
|
|
US8404718B2
(en)
|
2005-01-21 |
2013-03-26 |
Astex Therapeutics Limited |
Combinations of pyrazole kinase inhibitors
|
|
US20090088433A1
(en)
|
2005-01-26 |
2009-04-02 |
Bertrand Leblond |
Methods of using as analgesics 1-benzyl-1-hydroxy-2,3-diamino-propyl amines, 3-benzyl-3-hydroxy-2-amino-propionic acid amides and related compounds
|
|
US7576099B2
(en)
|
2005-02-28 |
2009-08-18 |
Renovis, Inc. |
Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
|
|
EA200701835A1
(ru)
*
|
2005-02-28 |
2008-02-28 |
Реновис, Инк. |
Амидные производные в качестве лигандов ионных каналов, их фармацевтические композиции и способы их применения
|
|
CA2601706C
(en)
|
2005-03-22 |
2016-09-20 |
Dana-Farber Cancer Institute, Inc. |
Treatment of protein degradation disorders
|
|
WO2007008994A2
(en)
*
|
2005-07-11 |
2007-01-18 |
Wyeth |
Glutamate aggrecanase inhibitors
|
|
JP4961773B2
(ja)
*
|
2005-07-29 |
2012-06-27 |
住友ベークライト株式会社 |
芳香族カルボン酸及びその酸ハロゲン化物
|
|
US8088804B2
(en)
|
2005-12-15 |
2012-01-03 |
Pfizer Inc. |
N-hydroxyamide derivatives possessing antibacterial activity
|
|
EP1991247B1
(en)
*
|
2006-02-14 |
2015-10-14 |
President and Fellows of Harvard College |
Bifunctional histone deacetylase inhibitors
|
|
AU2007248656B2
(en)
|
2006-05-03 |
2013-04-04 |
Dana-Farber Cancer Institute, Inc. |
Histone deacetylase and tubulin deacetylase inhibitors
|
|
EP2041099A1
(en)
|
2006-05-30 |
2009-04-01 |
AstraZeneca AB |
1, 3, 4 -oxadiazole derivatives as dgat1 inhibitors
|
|
DE102006033321A1
(de)
*
|
2006-07-17 |
2008-01-24 |
Westfälische Wilhelms-Universität Münster |
Medizinische Verwendung von N-Phenylpropenoyl-Aminosäurederivaten und verwandten Verbindungen
|
|
US7981874B2
(en)
|
2006-07-20 |
2011-07-19 |
Merck Sharp & Dohme Corp. |
Phosphorus derivatives as histone deacetylase inhibitors
|
|
WO2008014266A2
(en)
*
|
2006-07-24 |
2008-01-31 |
University Of Maryland, Baltimore |
Heme oxygenase inhibitors and methods of therapeutic use
|
|
TW200821276A
(en)
*
|
2006-08-18 |
2008-05-16 |
Leo Pharma As |
Substituted acetylenic compounds useful for the treatment of diseases
|
|
CA2661605A1
(en)
|
2006-08-31 |
2008-03-06 |
Schering Corporation |
Hydantoin derivatives useful as antibacterial agents
|
|
AU2007313250A1
(en)
*
|
2006-10-13 |
2008-04-24 |
Xtl Biopharmaceuticals Ltd |
Compounds and methods for treatment of HCV
|
|
US8962825B2
(en)
|
2006-10-30 |
2015-02-24 |
Glaxosmithkline Intellectual Property Development Limited |
Hydroxamates as inhibitors of histone deacetylase
|
|
US8563573B2
(en)
|
2007-11-02 |
2013-10-22 |
Vertex Pharmaceuticals Incorporated |
Azaindole derivatives as CFTR modulators
|
|
WO2008105515A1
(ja)
*
|
2007-02-28 |
2008-09-04 |
Taisho Pharmaceutical Co., Ltd. |
新規なヒドロキサム酸誘導体
|
|
DK2124562T3
(en)
|
2007-03-09 |
2016-08-01 |
Second Genome Inc |
BICYCLOHETEROARYLFORBINDELSER AS P2X7 modulators and uses thereof
|
|
WO2008154642A2
(en)
*
|
2007-06-12 |
2008-12-18 |
Achaogen, Inc. |
Antibacterial agents
|
|
CN101417937B
(zh)
*
|
2007-10-23 |
2013-05-29 |
中山大学 |
β-醛酮类抗菌化合物及其应用
|
|
US20110015158A1
(en)
|
2007-12-11 |
2011-01-20 |
Viamet Pharmaceuticals, Inc. |
Metalloenzyme inhibitors using metal binding moieties in combination with targeting moieties
|
|
WO2009081195A1
(en)
|
2007-12-20 |
2009-07-02 |
Astrazeneca Ab |
Carbamoyl compounds as dgat1 inhibitors 190
|
|
WO2009158369A1
(en)
|
2008-06-25 |
2009-12-30 |
Schering Corporation |
Synthesis and use of heterocyclic antibacterial agents
|
|
EP2321264B1
(en)
|
2008-07-23 |
2016-05-04 |
President and Fellows of Harvard College |
Deacetylase inhibitors and uses thereof
|
|
AU2009276343A1
(en)
*
|
2008-08-01 |
2010-02-04 |
Bioxiness Pharmaceuticals, Inc. |
Methionine analogs and methods of using same
|
|
CA2732045A1
(en)
*
|
2008-08-04 |
2010-02-11 |
Schering Corporation |
Urea derivatives as antibacterial agents
|
|
US8273900B2
(en)
|
2008-08-07 |
2012-09-25 |
Novartis Ag |
Organic compounds
|
|
US8372885B2
(en)
*
|
2008-09-17 |
2013-02-12 |
Novartis Ag |
Organic compounds and their uses
|
|
EP2334636A2
(en)
|
2008-09-19 |
2011-06-22 |
Pfizer Inc. |
Hydroxamic acid derivatives useful as antibacterial agents
|
|
EP2361242B1
(en)
|
2008-10-17 |
2018-08-01 |
Oryzon Genomics, S.A. |
Oxidase inhibitors and their use
|
|
EP2177502A1
(en)
*
|
2008-10-17 |
2010-04-21 |
Oryzon Genomics, S.A. |
Compounds and their use
|
|
EP2389362B1
(en)
|
2009-01-21 |
2019-12-11 |
Oryzon Genomics, S.A. |
Phenylcyclopropylamine derivatives and their medical use
|
|
WO2011005355A1
(en)
|
2009-05-07 |
2011-01-13 |
Achaogen, Inc. |
Combinations comprising a lpxc inhibitor and an antibiotic for use in the treatment of infections caused by gram-negative bacteria
|
|
BRPI1008165B1
(pt)
*
|
2009-05-25 |
2020-02-27 |
Chiesi Farmaceutici S.P.A. |
Uma combinação terapêutica compreendendo um surfactante pulmonar e um esteróide
|
|
RU2011152517A
(ru)
|
2009-06-19 |
2013-07-27 |
Астразенека Аб |
Пиразинкарбоксамиды в качестве ингибиторов dgat1
|
|
WO2011019393A2
(en)
|
2009-08-11 |
2011-02-17 |
President And Fellows Of Harvard College |
Class- and isoform-specific hdac inhibitors and uses thereof
|
|
FR2950057B1
(fr)
|
2009-09-17 |
2011-08-26 |
Galderma Res & Dev |
Nouveaux composes benzene-carboxylamides, leur procede de synthese et leur utilisation en medecine ainsi qu'en cosmetique
|
|
FR2950056B1
(fr)
|
2009-09-17 |
2011-08-26 |
Galderma Res & Dev |
Nouveaux composes benzene-carboxylamides, leur procede de synthese et leur utilisation en medecine ainsi qu'en cosmetique
|
|
KR101736218B1
(ko)
|
2009-09-25 |
2017-05-16 |
오리존 지노믹스 에스.에이. |
라이신 특이적 디메틸라아제-1 억제제 및 이의 용도
|
|
US8946296B2
(en)
|
2009-10-09 |
2015-02-03 |
Oryzon Genomics S.A. |
Substituted heteroaryl- and aryl-cyclopropylamine acetamides and their use
|
|
PL2512474T3
(pl)
|
2009-12-16 |
2015-03-31 |
Pfizer |
N-przyłączone pochodne kwasu hydroksamowego użyteczne jako środki przeciwbakteryjne
|
|
WO2011106573A2
(en)
|
2010-02-24 |
2011-09-01 |
Oryzon Genomics, S.A. |
Lysine demethylase inhibitors for diseases and disorders associated with hepadnaviridae
|
|
WO2011106574A2
(en)
|
2010-02-24 |
2011-09-01 |
Oryzon Genomics, S.A. |
Inhibitors for antiviral use
|
|
US8802868B2
(en)
|
2010-03-25 |
2014-08-12 |
Vertex Pharmaceuticals Incorporated |
Solid forms of (R)-1(2,2-difluorobenzo[D][1,3]dioxo1-5-yl)-N-(1-(2,3-dihydroxypropyl-6-fluoro-2-(1-hydroxy-2-methylpropan2-yl)-1H-Indol-5-yl)-Cyclopropanecarboxamide
|
|
BR122019020471B1
(pt)
|
2010-04-19 |
2021-06-22 |
Oryzon Genomics S.A. |
Inibidores da desmetilase específica para lisina 1, seus usos e método para sua identificação, e composições farmacêuticas
|
|
PH12012502087A1
(en)
|
2010-04-20 |
2015-04-15 |
Taisho Pharmaceutical Co Ltd |
Novel hydroxamic acid derivative
|
|
RU2569678C2
(ru)
|
2010-04-22 |
2015-11-27 |
Вертекс Фармасьютикалз Инкорпорейтед |
Способ получения циклоалкилкарбоксамидо-индольных соединений
|
|
US9006449B2
(en)
|
2010-07-29 |
2015-04-14 |
Oryzon Genomics, S.A. |
Cyclopropylamine derivatives useful as LSD1 inhibitors
|
|
WO2012013728A1
(en)
|
2010-07-29 |
2012-02-02 |
Oryzon Genomics S.A. |
Arylcyclopropylamine based demethylase inhibitors of lsd1 and their medical use
|
|
US9738604B2
(en)
|
2010-09-03 |
2017-08-22 |
Duke University |
Ethynylbenzene derivatives
|
|
WO2012045883A1
(en)
|
2010-10-08 |
2012-04-12 |
Oryzon Genomics S.A. |
Cyclopropylamine inhibitors of oxidases
|
|
MX2013005200A
(es)
|
2010-11-10 |
2013-06-28 |
Achaogen Inc |
Derivados de acido hidroxamico y su so en el tratamiento de infecciones bacterianas.
|
|
WO2012072713A2
(en)
|
2010-11-30 |
2012-06-07 |
Oryzon Genomics, S.A. |
Lysine demethylase inhibitors for diseases and disorders associated with flaviviridae
|
|
WO2012093101A1
(en)
|
2011-01-04 |
2012-07-12 |
Novartis Ag |
Indole compounds or analogues thereof useful for the treatment of age-related macular degeneration (amd)
|
|
EP3981395A1
(en)
|
2011-02-08 |
2022-04-13 |
Oryzon Genomics, S.A. |
Lysine demethylase inhibitors for myeloproliferative disorders
|
|
EP3578548A1
(en)
|
2011-02-22 |
2019-12-11 |
The General Hospital Corporation |
Antibiotic tolerance inhibitors
|
|
AP3336A
(en)
|
2011-03-07 |
2015-07-31 |
Pfizer |
Fluoro-pyridinone derivatives useful as antibacterial agents
|
|
CN103717582B
(zh)
|
2011-04-08 |
2015-09-30 |
辉瑞大药厂 |
用作抗菌剂的异*唑衍生物
|
|
SG193458A1
(en)
|
2011-04-08 |
2013-10-30 |
Pfizer |
Imidazole, pyrazole, and triazole derivatives useful as antibacterial agents
|
|
WO2013039947A1
(en)
|
2011-09-12 |
2013-03-21 |
Achaogen, Inc. |
Polymorphs of n-((s)-3-amino-1-(hydroxyamino)-3-methyl-1-oxobutan-2-yl)-4-(((1r,2r)-2-(hydroxymethyl)cyclopropyl)buta-1,3-diynyl)benzamide
|
|
JP6006609B2
(ja)
*
|
2011-10-19 |
2016-10-12 |
大正製薬株式会社 |
新規なヒドロキサム酸誘導体を含有する医薬
|
|
CN104203914B
(zh)
|
2011-10-20 |
2017-07-11 |
奥瑞泽恩基因组学股份有限公司 |
作为lsd1抑制剂的(杂)芳基环丙胺化合物
|
|
UA116765C2
(uk)
|
2011-10-20 |
2018-05-10 |
Орізон Джіномікс, С.А. |
(гетеро)арилциклопропіламіни як інгібітори lsd1
|
|
CN104254518A
(zh)
*
|
2012-02-16 |
2014-12-31 |
阿奇克斯制药公司 |
线性肽抗生素
|
|
WO2013170165A1
(en)
|
2012-05-10 |
2013-11-14 |
Achaogen, Inc. |
Antibacterial agents
|
|
JP6209605B2
(ja)
|
2012-06-28 |
2017-10-04 |
ノバルティス アーゲー |
ピロリジン誘導体、および補体経路調節因子としてのその使用
|
|
JP6155332B2
(ja)
|
2012-06-28 |
2017-06-28 |
ノバルティス アーゲー |
ピロリジン誘導体、および補体経路調節因子としてのその使用
|
|
WO2014002052A1
(en)
|
2012-06-28 |
2014-01-03 |
Novartis Ag |
Pyrrolidine derivatives and their use as complement pathway modulators
|
|
ES2712190T3
(es)
|
2012-06-28 |
2019-05-09 |
Novartis Ag |
Moduladores de la vía del complemento y sus usos
|
|
JP6273274B2
(ja)
|
2012-06-28 |
2018-01-31 |
ノバルティス アーゲー |
補体経路モジュレーターおよびその使用
|
|
EA201590200A1
(ru)
|
2012-07-12 |
2015-08-31 |
Новартис Аг |
Модуляторы пути активации комплемента и их применение
|
|
CN103012207B
(zh)
*
|
2012-12-29 |
2015-05-27 |
吉首大学 |
二芳基丙酰-n-甲基氧肟酸类尿素酶抑制剂及其合成和用途
|
|
WO2014165075A1
(en)
|
2013-03-12 |
2014-10-09 |
Achaogen, Inc. |
Antibacterial agents
|
|
TR201911245T4
(tr)
*
|
2013-03-15 |
2019-08-21 |
Fujifilm Toyama Chemical Co Ltd |
Yeni hidroksamik asit türevi veya bunun tuzu.
|
|
WO2014160649A1
(en)
*
|
2013-03-29 |
2014-10-02 |
Novartis Ag |
Hydroxamic acid derivatives as lpxc inhibitors for the treatment of bacterial infections
|
|
US9908851B2
(en)
|
2013-08-16 |
2018-03-06 |
Duke University |
2-piperidinyl substituted N,3-dihydroxybutanamides
|
|
CA2921427A1
(en)
*
|
2013-08-16 |
2015-02-19 |
Duke University |
Substituted hydroxamic acid compounds
|
|
US10189786B2
(en)
*
|
2013-08-16 |
2019-01-29 |
Duke University |
Antibacterial compounds
|
|
GB201315335D0
(en)
|
2013-08-29 |
2013-10-09 |
Of Singapore |
Amino diacids containing peptide modifiers
|
|
US9539305B1
(en)
|
2014-03-14 |
2017-01-10 |
Fleurir Abx Llc |
Pristinamycin compositions, LpxC compositions, their improvements, and combinations thereof
|
|
PT3131582T
(pt)
|
2014-04-15 |
2018-10-08 |
Vertex Pharma |
Composições farmacêuticas para o tratamento de doenças mediadas pelo regulador de condutância transmembranar da fibrose quística
|
|
CN106573924B
(zh)
|
2014-04-22 |
2019-06-25 |
诺华股份有限公司 |
作为LpxC抑制剂的异噁唑啉异羟肟酸衍生物
|
|
KR20170048546A
(ko)
|
2014-09-12 |
2017-05-08 |
토야마 케미칼 컴퍼니 리미티드 |
신규 히드록삼산 유도체 또는 그 염을 함유하는 의약 조성물
|
|
JPWO2016039432A1
(ja)
|
2014-09-12 |
2017-06-22 |
富山化学工業株式会社 |
新規なヒドロキサム酸誘導体および抗菌性物質を組み合わせて使用する方法
|
|
CN104341476A
(zh)
*
|
2014-10-11 |
2015-02-11 |
吉首大学 |
利奈唑胺-肌苷型多靶点抗菌化合物及其制法和用途
|
|
CN104327140B
(zh)
*
|
2014-10-11 |
2016-06-15 |
吉首大学 |
噁唑烷酮-腺苷型多靶点抗菌化合物及其制法和用途
|
|
CN104341475A
(zh)
*
|
2014-10-11 |
2015-02-11 |
吉首大学 |
利奈唑胺-腺苷型多靶点抗菌化合物及其制法和用途
|
|
CN104231024B
(zh)
*
|
2014-10-11 |
2016-06-15 |
吉首大学 |
噁二唑-肌苷型化合物作为TyrRS抑制剂及其制法和用途
|
|
CN104262433B
(zh)
*
|
2014-10-11 |
2016-06-15 |
吉首大学 |
噁二唑-腺苷型化合物作为TyrRS抑制剂及其制法和用途
|
|
EA032138B1
(ru)
|
2014-12-16 |
2019-04-30 |
Новартис Аг |
СОЕДИНЕНИЯ ИЗОКСАЗОЛГИДРОКСАМИНОВОЙ КИСЛОТЫ В КАЧЕСТВЕ ИНГИБИТОРОВ LpxC
|
|
CN105777464B
(zh)
*
|
2014-12-26 |
2020-09-29 |
中国科学院上海药物研究所 |
异羟肟酸衍生物及其制备方法和应用
|
|
KR20180011843A
(ko)
|
2015-06-11 |
2018-02-02 |
바실리어 파마슈티카 인터내셔널 리미티드 |
유출-펌프 억제제 및 이의 치료적 용도
|
|
WO2017042099A1
(en)
*
|
2015-09-09 |
2017-03-16 |
Basilea Pharmaceutica Ag |
Efflux-pump inhibitors and therapeutic uses thereof
|
|
EP3374350B1
(en)
|
2015-11-09 |
2022-01-05 |
Forge Therapeutics, Inc. |
Hydroxypyridinone and hydroxypyrimidinone based compounds for treating bacterial infections
|
|
US10611747B2
(en)
|
2015-11-09 |
2020-04-07 |
Forge Therapeutics, Inc. |
Pyrone based compounds for treating bacterial infections
|
|
RU2018124788A
(ru)
*
|
2015-12-08 |
2020-01-15 |
Глэксосмитклайн Интеллекчуал Проперти Дивелопмент Лимитед |
Замещенные бензазиноны в качестве антибактериальных соединений
|
|
EP3426674A4
(en)
|
2016-03-09 |
2019-08-14 |
Blade Therapeutics, Inc. |
CYCLIC KETO AMID COMPOUNDS AS CALPAIN MODULATORS AND METHOD FOR THE PRODUCTION AND USE THEREOF
|
|
WO2017182433A1
(en)
*
|
2016-04-18 |
2017-10-26 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Novel inhibitors of meprin alpha and beta
|
|
EP3448375B1
(en)
|
2016-04-25 |
2023-09-27 |
Duke University |
Benzoylglycine derivatives and methods of making and using same
|
|
CA3026356A1
(en)
|
2016-06-14 |
2017-12-21 |
Novartis Ag |
Crystalline form of (r)-4-(5-(cyclopropylethynyl)isoxazol-3-yl)-n-hydroxy-2-methyl-2-(methylsulfonyl)butanamide as an antibacterial agent
|
|
JP7164521B2
(ja)
|
2016-06-21 |
2022-11-01 |
オリオン・オフサルモロジー・エルエルシー |
炭素環式プロリンアミド誘導体
|
|
CA3026505A1
(en)
|
2016-06-21 |
2017-12-28 |
Orion Ophthalmology LLC |
Aliphatic prolinamide derivatives
|
|
MX392422B
(es)
|
2016-06-21 |
2025-03-24 |
Orion Ophthalmology LLC |
Derivados de prolinamida heterociclica
|
|
WO2017223349A1
(en)
|
2016-06-23 |
2017-12-28 |
Achaogen, Inc. |
Antibacterial agents
|
|
US11292801B2
(en)
|
2016-07-05 |
2022-04-05 |
Blade Therapeutics, Inc. |
Calpain modulators and therapeutic uses thereof
|
|
AU2017336523B2
(en)
|
2016-09-28 |
2022-07-21 |
Blade Therapeutics, Inc. |
Calpain modulators and therapeutic uses thereof
|
|
BR112019013016B1
(pt)
|
2016-12-23 |
2023-05-02 |
Intervet International B.V. |
Compostos antibacterianos, composição farmacêutica que os compreende e uso dos referidos compostos
|
|
AR110440A1
(es)
|
2016-12-23 |
2019-03-27 |
Intervet Int Bv |
Compuestos para el tratamiento de la enfermedad respiratoria bovina o porcina
|
|
US11021471B2
(en)
|
2017-05-10 |
2021-06-01 |
Forge Therapeutics, Inc. |
Antibacterial compounds
|
|
WO2018213185A1
(en)
*
|
2017-05-17 |
2018-11-22 |
Drexel University |
Rela inhibitors for biofilm disruption
|
|
WO2019014352A1
(en)
|
2017-07-11 |
2019-01-17 |
Vertex Pharmaceuticals Incorporated |
CARBOXAMIDES AS INHIBITORS OF SODIUM CHANNELS
|
|
BR112020001619A2
(pt)
|
2017-07-27 |
2020-07-21 |
BioMendics, LLC |
tolanos substituídos para a modulação da colonização microbiana
|
|
CA3090833A1
(en)
*
|
2018-02-10 |
2019-08-15 |
Kbp Biosciences Co., Ltd. |
Compound acting as antibiotics
|
|
AU2019345150A1
(en)
*
|
2018-09-20 |
2021-05-13 |
Blacksmith Medicines, Inc. |
Antibacterial compounds
|
|
WO2020092394A1
(en)
|
2018-10-30 |
2020-05-07 |
Gilead Sciences, Inc. |
Imidazopyridine derivatives as alpha4beta7 integrin inhibitors
|
|
PL3873605T3
(pl)
|
2018-10-30 |
2025-03-03 |
Gilead Sciences, Inc. |
Związki hamujące integrynę alfa4beta7
|
|
DK3873884T3
(da)
|
2018-10-30 |
2025-02-17 |
Gilead Sciences Inc |
3-(quinolin-8-yl)-1,4-dihydropyrido[3,4-d]pyrimidin-2,4-dion-derivater som alpha4beta7-integrinhæmmere til behandling af inflammatoriske sygdomme
|
|
EP3873897B1
(en)
|
2018-10-30 |
2024-08-14 |
Gilead Sciences, Inc. |
N-benzoyl-phenylalanine derivatives as alpha4beta7 integrin inhibitors for treating inflammatory diseases
|
|
US12440481B2
(en)
|
2019-01-10 |
2025-10-14 |
Vertex Pharmaceuticals Incorporated |
Esters and carbamates as modulators of sodium channels
|
|
WO2020146682A1
(en)
|
2019-01-10 |
2020-07-16 |
Vertex Pharmaceuticals Incorporated |
Carboxamides as modulators of sodium channels
|
|
US20220117893A1
(en)
*
|
2019-02-22 |
2022-04-21 |
The Blue Group Llc |
Inhalable therapeutic agent
|
|
US11578069B2
(en)
|
2019-08-14 |
2023-02-14 |
Gilead Sciences, Inc. |
Compounds for inhibition of α4 β7 integrin
|
|
CN110563611B
(zh)
|
2019-09-19 |
2021-02-02 |
中国医学科学院医药生物技术研究所 |
一种异羟肟酸类衍生物及其制备方法和应用
|
|
PH12022551379A1
(en)
|
2019-12-06 |
2023-05-03 |
Vertex Pharma |
Substituted tetrahydrofurans as modulators of sodium channels
|
|
CN111254091B
(zh)
*
|
2020-01-20 |
2022-04-19 |
浙江工业大学 |
一种嗜麦芽窄食单胞菌gyh及其在降解氯代烃类污染物中的应用
|
|
WO2021195260A1
(en)
|
2020-03-25 |
2021-09-30 |
Forge Therapeutics, Inc. |
Lpxc inhibitor and methods of making
|
|
CA3183740A1
(en)
|
2020-06-10 |
2021-12-16 |
Aligos Therapeutics, Inc. |
Anti-viral compounds for treating coronavirus, picornavirus, and norovirus infections
|
|
DK4347031T3
(da)
|
2021-06-04 |
2025-12-01 |
Vertex Pharma |
N-(hydroxyalkyl-(hetero)aryl)-tetrahydrofuran-carboxamider som modulatorer af natriumkanaler
|
|
WO2023283256A1
(en)
|
2021-07-09 |
2023-01-12 |
Aligos Therapeutics, Inc. |
Anti-viral compounds
|
|
WO2023043816A1
(en)
|
2021-09-17 |
2023-03-23 |
Aligos Therapeutics, Inc. |
Anti-viral compounds for treating coronavirus, picornavirus, and norovirus infections
|
|
MX2024003859A
(es)
|
2021-09-28 |
2024-05-21 |
Blacksmith Medicines Inc |
Inhibidores de lpxc y usos de estos.
|
|
WO2023128033A1
(ko)
*
|
2021-12-31 |
2023-07-06 |
(주)앰틱스바이오 |
감염성 진균의 바이오필름 생성을 억제하는 신규한 항진균용 조성물
|
|
CN116730870B
(zh)
*
|
2023-08-08 |
2023-10-13 |
中国医学科学院医药生物技术研究所 |
异羟肟酸类化合物或其可药用盐、及其用途和制备方法
|
|
CN119350185A
(zh)
*
|
2024-10-08 |
2025-01-24 |
聊城大学 |
一种联苯羟肟类衍生物及其制备方法和用途
|